Summary and prospect of perioperative comprehensive treatment for gastric cancer in China
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 1
Abstract
Most of the patients with gastric cancer in China have been at the middle and advanced stages during diagnostic and treatment with poor prognosis overall. Perioperative radiotherapy, chemotherapy, immune therapy and other comprehensive treatment methods for gastric cancer patients preoperative and intraoperation may reduce tumor staging, increase the rate of surgical resection and prolong the time of patient survival. Perioperative comprehensive treatment has developed more than 30 years in China. Many results from relevant research were gotten combined with laying down the consensus and guidelines, and applied to clinic in recent years. With the emergence and development of new technologies and new strategies for comprehensive treatment, perioperative comprehensive treatment and conversion therapy will improve at much extent the rate of survival for gastric cancer patients in China.
Authors and Affiliations
Wentao LIU, Fukun LIU
Keywords
Related Articles
- EP ID EP750841
- DOI 10.16139/j.1007-9610.2023.01.06
- Views 54
- Downloads 0
Study on effects of percutaneous transhepatic gallbladder drainage in treatment of acute biliary pancreatitis
[Objective] To evaluate retrospectively the clinical efficacy of percutaneous transhepatic gallbladder drainage (PTGBD) in the patients with acute biliary pancreatitis (ABP). [Methods] A total of 244 patients with ABP re...
Current status and future perspective of hepatic artery infusion chemotherapy
Effect of mismatch repair genes expression in right colon cancer on pathological characteristics
[Objective] To investigate the defect of expression of mismatch repair genes(MMR) including MLH1, MSH2, MSH6 and PMS2 in sporadic colon cancer, and analyze the expression of MMR related to pathological change of patients...
Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells
[Objective] To study the effect of Ki-67 gene silencing on doxorubicin (DOX) resistance in breast cancer MCF-7 cells. [Methods] Liposome transient transfection method and breast cancer MCF-7 cells cultured in vitro were...
Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
Advanced differentiated thyroid carcinoma (ADTC) lacks effective treatment options, and has a poor prognosis, which is an urgent clinical problem to be resolved. Targeted multikinase inhibitor(MKI) has been approved for...